Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy

Sponsor:

COG

Sponsor Study ID:

ALTE11C2

CTO #:

102968

NCT Number:

NCT01790152

Phase:

N/A

Protocol Type:

Other

Age Group:

Both

Disease Sites:

Myeloid and Monocytic Leukemia; Non-Hodgkin's Lymphoma

Study Objectives:

This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of dexrazoxane hydrochloride on cells. It may also help doctors understand how well patients respond to treatment.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)